Stock News Releases and Press Releases OTCMKTS, NASDAQ and NYSE Markets

PURCHASE, N.Y., July 02, 2024 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical stage company developing drugs that treat neurodegenerative disorders, today announced that abstracts summarizing clinical e...

PSEG To Announce Second Quarter 2024 Financial Results On July 30 PR Newswire NEWARK, N.J. , July 2, 2024 /PRNewswire/ -- Public Service Enterprise Group Incorporated (PSEG) will host its second quarter 2024 earnings call at 11:00 a.m. ET on Tuesday , July 3...

Vancouver, British Columbia--(Newsfile Corp. - July 2, 2024) - Kenorland Minerals Ltd. (TSXV: KLD) (OTCQX: KLDCF) (FSE: 3WQ0) (" Kenorland " or the " Company ") is pleased to announce the engagement of BBA Consultants (" BBA "), an engineering consulting firm, in preparation for a potential aut...

CARVYKTI® (ciltacabtagene autoleucel) achieved statistically significant and clinically meaningful improvement in overall survival in landmark CARTITUDE-4 study PR Newswire CARVYKTI ® is the first and only BCMA-targeted CAR-T cell therapy approved by the U.S....

NYSE: HUM Lawsuit Alert: Investors who lost money with shares of Humana Inc. should contact the Shareholders Foundation PR Newswire SAN DIEGO , July 2, 2024 /PRNewswire/ -- The Shareholders Foundation, Inc. announces that a lawsuit was filed for certain investors...

ATI Announces Webcast for Second Quarter 2024 Results PR Newswire DALLAS , July 2, 2024 /PRNewswire/ -- ATI (NYSE: ATI) has scheduled the live webcast for its second quarter 2024 earnings conference call on Tuesday, August 6 , 2024, at 7:30 a.m...

U.S. Department of Justice Informs Viatris That It No Longer Considers Mylan a Subject of Generic Drug Industry Antitrust Investigation PR Newswire PITTSBURGH , July 2, 2024 /PRNewswire/ -- Viatris Inc. (NASDAQ: VTRS) today announced that the Antitrust Divisi...

GAITHERSBURG, Md., July 02, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that members of the Company’s management team will be hosting one-on-one meetings with institutional investors at the Leerink Partners Therape...

CAMBRIDGE, MA / ACCESSWIRE / July 2, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced a project award of $176 million through the Rapid Response Partnership Vehicle (RRPV) to accelerate the development of mRNA-based pandemic influenza vaccines. The RRPV is a Consortium funded by the Biomedical...

ATLANTA, July 02, 2024 (GLOBE NEWSWIRE) -- Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of solutions that enable healthcare providers to improve financial performance, announced that it has signed a new contract for the use of eValuator with a 750-bed, Epic-EHR based...